The Operating System
for Biologicals.
Next-Generation Nutrition
A Knowledge Intensive Company developing clinically potent crops inside advanced vertical-farming systems — creating high-value ingredients for nutraceutical and pharma-adjacent products using Bioencapsulated Peptide Synthesis
Detailed financial metrics are restricted to verified investors.
What We Do
We combine precision agriculture, clinical nutrition and bioactive optimisation to create high-value ingredients for sports nutrition, pharma and GLP-1 receptor agonists (eg. similar to Ozempic, Mounjaro etc).
Solaris Biolabs is advancing its Round 3 growth phase. To learn more about our qualifying EIS opportunities, please verify your investor status below.
Why the Industry Needs Us
Consumers demand precision nutrition, yet most functional ingredients fall short of clinical standards. Industry demand for high-potency, contaminant-free, traceable ingredients is at an all-time high.
Inconsistent Potency
Variable bioactive concentrations compromise efficacy in functional ingredients.
Contamination Risk
Pesticides and heavy metals present serious safety concerns for consumers.
Supply Chain Degradation
Long transport routes reduce nutritional value before products reach consumers.
Climate Vulnerability
Traditional farming is exposed to weather volatility and climate change.
